Azra AI Acquires Blackford Analysis
Oct 20, 2026
Acquisitions
Dassault Systèmes to Acquire ArisGlobal from Nordic Capital
Jul 23, 2026
Nordic Capital has agreed to sell life sciences software provider ArisGlobal to Dassault Systèmes. The deal marks a full exit for Nordic Capital following its investment in 2019 and is expected to close in the second half of 2026, pending regulatory approval.
In a press release, Nordic Capital announced that it has entered into a definitive agreement to sell ArisGlobal to Dassault Systèmes. The transaction represents a full exit for Nordic Capital and is expected to close in the second half of 2026, subject to regulatory approvals.
ArisGlobal, founded in 1989 and based in Waltham, Massachusetts, develops regulatory, safety, and quality software for the life sciences industry. Its LifeSphere platform integrates compliance, pharmacovigilance, and clinical data workflows, while incorporating automation and AI capabilities to reduce manual processing.
Nordic Capital first invested in ArisGlobal in 2019 and made a follow-on investment in 2021. During its ownership, Nordic Capital and ArisGlobal’s management team migrated the company’s products to a cloud-based architecture, expanded the product portfolio, and launched NavaX, a generative AI solution for safety case processing.
Following the acquisition, Dassault Systèmes will combine its research, clinical development, and manufacturing tools with ArisGlobal’s regulatory and safety software to create a broader offering across the life sciences value chain.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030More from Life Sciences
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 Mosaic Raises $47M for Blood Vessel Surgery Robots Nov 11 Kardi AI Raises €5.3 Million for Heart Monitoring Expansion Nov 11 Switchpoint Bio raises $5.3 million for AI epigenomics platform Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and OptumFree newsletter
AI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
XRlabs Raises €7.48 Million for Surgical AI
Oct 20, 2026
Funding
Axon Invests $1.2 Billion in Skydio
Nov 05, 2026
Funding
Arda Raises $230 Million at $1.5 Billion Valuation
Oct 20, 2026
Funding
OpenAI acquires Orchestra Bio to bring AI agents into drug development
Oct 20, 2026
Acquisitions
Atlas Bio raises $12.5 million for virtual drug trials
Oct 27, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.